Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012284 |
---|---|
Receipt number | R000014291 |
Scientific Title | Multicenter, randomized, double-blind, placebo-controlled parallel-group comparative study to evaluate the efficacy of low-dose chlormadinone acetate on the rate of continued active surveillance of patients with low-risk prostate cancer. |
Date of disclosure of the study information | 2013/11/13 |
Last modified on | 2022/11/21 13:13:56 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/11/13 10:18:42 | ||
2 | Update | 2013/12/19 14:11:37 | Developmental phase |
|
3 | Update | 2014/04/08 10:35:33 | Recruitment status |
|
4 | Update | 2016/11/14 16:29:09 | Last name of contact person Last name of contact person Name of primary person or sponsor Organization |
|
5 | Update | 2016/11/15 09:24:49 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
6 | Update | 2016/11/15 09:26:45 | Institutions |
|
7 | Update | 2017/01/30 15:57:51 | Recruitment status |
|
8 | Update | 2017/05/17 14:13:45 | Institutions |
|
9 | Update | 2017/05/17 14:15:27 | Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
10 | Update | 2018/10/12 13:38:52 | Public title |
|
11 | Update | 2018/11/20 10:22:43 | Interventions/Control_1 |
|
12 | Update | 2019/05/20 09:21:50 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization1 Organization Organization Address Address Tel |
|
13 | Update | 2019/05/20 09:23:36 | Number of participants that the trial has enrolled |
|
14 | Update | 2019/05/20 09:25:16 | Date of IRB |
|
15 | Update | 2022/11/21 13:13:56 | Recruitment status |